| Application no. and date | 11749629.9 (espacenet) (Federated) (European Patent Register), 20110805 | | Patent/reg. no. and date | DK/EP 2601529, 20161221 | | Publication date | 20130612 | | Priority no. and date | US 371537 P, 20100806, US 201161443955 P, 20110217 | | EP pub. no. and date |
EP 2601529 20130612 | | Effective date | | | Applicant/owner | The United States of America, as represented by
The Secretary, Department of Health and
Human Services, Office of Technology Transfer
National Institutes of Health
6011 Executive Boulevard
Suite 325
MSC 7660
Bethesda, Maryland 20892-7660, US | | Applicant ref. no. | P064645 | | Inventor | GILDERSLEEVE, Jeffrey, 6572 Whetstone Drive
Frederick
Maryland 21703, US,
CAMPBELL, Christopher, 1905 Linden Avenue
Baltimore
Maryland 21217, US,
OYELARAN, Oyindasola, 71 High Street 1
North Adams
Massachusetts 01247, US,
GULLEY, James, 8011 Glenside Drive
Takoma Park
Maryland 20912, US,
SCHLOM, Jeffrey, 10301 Sorrel Avenue
Potomac
Maryland 20854, US | | Representative | Larsen & Birkeholm A/S Skandinavisk Patentbureau, Banegårdspladsen 1, 1570 København V | | Opponent | | | IPC Class | G01N 33/574 (2006.01) | | Title | Biomarkører til forudsigelse af reaktionen på en cancervaccine | | Int. application no. | US2011046799 | | Int. publication no. | WO2012019125 | | Related patent (certificate) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
